Investment Summary

Goldman Sachs Merchant Banking Invests In Ascletis

On December 2, 2015, private equity firm Goldman Sachs Merchant Banking invested in life science company Ascletis

Investment Highlights
  • This is Goldman Sachs Merchant Banking’s 2nd transaction in the Life Science sector.
  • This is Goldman Sachs Merchant Banking’s 85th transaction in the United States.
  • This is Goldman Sachs Merchant Banking’s 1st transaction in North Carolina.

Investment Summary
Date 2015-12-02
Target Ascletis
Sector Life Science
Investor(s) Goldman Sachs Merchant Banking
Deal Type Growth Capital

Target

Ascletis

Chapel Hill, North Carolina, United States
Ascletis, Inc. is a biotechnology company dedicated to discovering, developing and commercializing new treatments for infectious diseases and cancer.

Search 202,137 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Investor(S) 1

Investor

Goldman Sachs Merchant Banking

New York, New York, United States
Category Private Equity Firm
Founded 1986
PE ASSETS 155.0B USD
Size Mega
Type Sector Agnostic
DESCRIPTION

Goldman Sachs Merchant Banking Division is the investment arm of Goldman Sachs. The primary corporate investment group within the Merchant Banking Division is Goldman Sachs' direct investment arm. GS's direct investment arm consists of GS Capital Partners, GS Mezzanine Partners, and GS Growth Partners. GS Capital Partners is the direct corporate equity investment group which seeks LBO, recapitalization, and growth investments to help fund acquisitions, expansions, recapitalizations, restructurings, buyouts, and take privates. GS Capital Partners looks to invest between $50 and $800 million in opportunities in North/South America, Europe, Asia. GS Mezzanine Partners is the junior capital arm of Goldman Sachs. GS Mezzanine looks to invest between $200 million and and $800 million in transactions valued up to $10 billion. Investment proceeds are used to fund leveraged buyouts, expansion financings, recapitalizations, acquisitions, and restructurings. GS Growth looks to invest in growth equity transactions. The unit seeks to commit $20 to $200 million per investment. Other units within GS's merchant banking division include Real Estate, Infrastructure, and Urban Investments. Goldman Sachs Merchant Banking Division is based in New York City.

DEAL STATS #
Overall 120 of 184
Sector (Life Science) 2 of 6
Type (Growth Capital) 13 of 28
State (North Carolina) 1 of 2
Country (United States) 85 of 128
Year (2015) 16 of 16
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-11-18 Precisely

Burlington, Massachusetts, United States

Precisely is a provider of data integrity software. The Company provides accuracy, consistency, and context in data for 12,000 customers in more than 100 countries. Precisely’s data integration, data quality, data governance, location intelligence, and data enrichment products power better business decisions to create better outcomes. Precisely is based in Burlington, Massachusetts.

Sell -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2016-02-02 OutSystems

Boston, Massachusetts, United States

OutSystems provides a platform that enables enterprise customers to rapidly develop software applications in a “low code” environment using a visual, model-based approach, instead of traditional programming methods. OutSystems was founded in 2001 and is based in Boston, Massachusetts.

Buy -
Mergr

Product

Company

Legal